Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hMPV), human rhinoviruses (HRV), and infection by influenza virus type A (IAV) and pharmaceutical composition comprising the anionically modified polyallylamine derivative

US Patent 9925215 · Granted Mar 27, 2018

Assignee

Inventors

View full patent text on Google Patents →